Patient Enrollment in Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Patient Enrollment in Clinical Trials in Brazil

Patient Enrollment in Clinical Trials in Brazil – Full Service CRO

Patient enrollment is a critical aspect of clinical trials, shaping the success and reliability of research outcomes. Brazil has emerged as a dynamic hub for clinical research, offering a diverse patient population, renowned medical centers, and a supportive regulatory framework.

This blog explores the landscape of patient enrollment in clinical trials in Brazil, highlighting the opportunities and challenges faced by researchers, sponsors, and patients.

The Vast Potential for Patient Enrollment

Brazil presents numerous opportunities for patient enrollment in clinical trials. With a population exceeding 210 million people, Brazil offers a diverse gene pool, encompassing various ethnicities, races, and genetic backgrounds. This diversity enhances the generalizability of trial results and allows for the study of diseases and treatments across different patient groups.

Furthermore, Brazil boasts a robust healthcare infrastructure, including world-class hospitals and research centers. The country is home to highly skilled investigators and experienced clinical research professionals who ensure high-quality data collection, patient care, and adherence to ethical standards.

Brazil’s regulatory environment is also conducive to patient enrollment. The National Health Surveillance Agency (ANVISA) has implemented efficient and streamlined processes for trial approval, reducing bureaucratic obstacles and expediting the initiation of clinical trials.

This supportive regulatory framework enables researchers and sponsors to promptly start trials, facilitating timely patient enrollment.

Patient Enrollment in Clinical Trials in Brazil

Patient Enrollment in Clinical Trials in Brazil

Patient Enrollment in Clinical Trials in Brazil

Challenges in Patient Enrollment

Despite the opportunities, Brazil faces certain challenges in patient enrollment for clinical trials. One significant obstacle is the limited awareness and understanding of clinical research among the general population.

Many potential participants are unfamiliar with the benefits of participating in trials and may hold misconceptions about the risks involved. Educating the public and dispelling myths through targeted awareness campaigns is crucial for increasing recruitment rates.

Language and cultural barriers can also impact patient enrollment. While Portuguese is the official language, Brazil is a culturally diverse nation with various regional dialects and indigenous populations.

Researchers and sponsors must employ culturally sensitive recruitment strategies, including translated study materials and engagement with local communities, to ensure effective communication and inclusivity.

Socioeconomic factors can also influence patient enrollment. Brazil is a country with economic disparities, and access to healthcare facilities and financial limitations may deter individuals from participating in clinical trials.

It is essential to develop strategies that address these barriers, such as providing transportation support, compensating participants for their time and expenses, and collaborating with community organizations to overcome financial constraints.

Strategies and Future Outlook

To enhance patient enrollment in clinical trials in Brazil, several strategies can be implemented. Firstly, partnerships and collaborations between academic institutions, hospitals, pharmaceutical companies, and research organizations can streamline the recruitment process.

Sharing patient databases, establishing referral networks, and creating centralized platforms for trial information can facilitate patient identification and enrollment.

Secondly, targeted recruitment strategies should be developed, involving healthcare providers in the referral process. Educating physicians and other healthcare professionals about ongoing trials and their potential benefits can enhance their involvement and encourage them to refer eligible patients.

Additionally, leveraging social media platforms, patient advocacy groups, and community outreach initiatives can raise awareness and engage potential participants.

Moreover, digital technologies play a crucial role in patient enrollment. Online platforms, mobile applications, and telemedicine services can expand the reach of trial information, facilitate remote monitoring, and improve communication between researchers and patients. These technological advancements can overcome geographical barriers and increase accessibility to clinical trials.

In the future, Brazil’s regulatory bodies can continue to streamline approval processes, aligning them with international standards to attract more global sponsors.

Investing in research infrastructure, fostering collaboration among research institutions, and providing support for training and capacity building will further strengthen Brazil’s position as a leading destination for clinical trials.


Patient enrollment in clinical trials in Brazil holds immense potential for advancing medical knowledge and improving healthcare outcomes. The country’s diverse patient population, robust healthcare infrastructure, and supportive regulatory framework create a favorable environment for conducting clinical research.

However, challenges such as limited awareness, language barriers, and socioeconomic factors need to be addressed.

Patient Enrollment in Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Patient Enrollment in Clinical Trials in Brazil

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Patient Enrollment in Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Patient Enrollment in Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Patient Enrollment in Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Patient Enrollment in Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Patient Enrollment in Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Patient Enrollment in Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Patient Enrollment in Clinical Trials in Brazil

The Cohortias Team

Patient Enrollment in Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Patient Enrollment in Clinical Trials in Brazil

Network & Partnerships